The red skin syndromes: corticosteroid addiction and withdrawal

References

• Rapaport MJ, Rapaport V. Eyelid dermatitis to red face syndrome to cure: clinical experience in 100 cases. J. Am. Acad. Dermatol.41, 435–442 (1999).
   PubMed Web of Science ®Google Scholar
• Engrasser PG, Hogan DJ, Stewart LA, Zug KA. Evaluation and management of the “red face”. Am. J. Contact Dermat.10, 236–239 (1999).
   PubMedGoogle Scholar
• Garner LA, Cruz PD Jr. Worsening of a recurrent facial eruption despite treatment. Am. J. Contact Dermat.10, 81–82 (1999).
   PubMedGoogle Scholar
• Katz AS, Sherertz EF. Facial dermatitis: patch test results and final diagnosis. Am. J. Contact Dermat.10, 153–156 (1999).
   PubMedGoogle Scholar
• Bender B, Prestia AE, Lynfield YL. The headlight sign in neurodermatitis. Cutis5, 1406–1408 (1969).
   Google Scholar
• Uehara M, Mitsuyoshi O, Sugiura H. Diagnosis and management of the red face syndrome. Dermatol. Ther.1, 19–23 (1996).
   Google Scholar
• Tada J, Yamasaki H, Toi Y et al. Is the face and neck pattern of atopic dermatitis in Japan a special variant? Am. J. Contact Dermat.10, 7–11 (1999).
   PubMedGoogle Scholar
• Rapaport MJ, Rapaport V. Prolonged erythema after facial laser resurfacing or phenol peel secondary to corticosteroid addiction. Dermatol. Surg.25, 781–785 (1999).
   PubMed Web of Science ®Google Scholar
• Ruiz–Esparza J, Barba-Gomez JM, Gomez-De La Torre OL, David L. Erythema after laser skin resurfacing. Dermatol. Surg.24, 31–34 (1998).
   PubMed Web of Science ®Google Scholar
• Nanni CA, Alster TS. Complications of cutaneous laser surgery. Dermatol. Surg.24, 209–219 (1998).
   PubMed Web of Science ®Google Scholar
• Maloney BP, Millman B, Monheit G, McCollough EG. The etiology of prolonged erythema after chemical peel. Dermatol. Surg.24, 337–341 (1998).
   PubMed Web of Science ®Google Scholar
• Rendon-Pellerano MI, Lentini J, Eaglstein WE, Kirsner RS, Hanft K, Pardo RJ. Laser resurfacing: usual and unusual complications. Dermatol. Surg.25, 360–367 (1999).
   PubMed Web of Science ®Google Scholar
• Ratner D, Tse Y, Marchell N et al. Cutaneous laser resurfacing. J. Am. Acad. Dermatol.41, 365–389 (1999).
   PubMed Web of Science ®Google Scholar
• Fisher AA. Part I. “Status cosmeticus”: a cosmetic intolerance syndrome. Cutis46, 109–110 (1990).
   PubMed Web of Science ®Google Scholar
• Fisher AA. Part II. The management of eyelid dermatitis in patients with “status cosmeticus”: the cosmetic intolerance syndrome. Cutis46, 199–201 (1990).
   PubMed Web of Science ®Google Scholar
• Fisher AA. Cosmetic intolerance syndrome. In: Contact Dermatitis, 4th Edition. Rietschel R, Fowler J (Eds). Williams & Wilkins PA, USA, 316–318 (1995).
   Google Scholar
• Fisher BK. The red scrotum syndrome. Cutis60, 139–141 (1997).
   PubMed Web of Science ®Google Scholar
• Rapaport M. Letters to the editor. Cutis61, 128B (1998).
   Google Scholar
• Fisher BK. Letters to the Editor. Cutis61, 128B (1998).
   Google Scholar
• Lynch PJ, Edwards L. Penile and scrotal pain. In: Genital Dermatology. Churchill Livingstone, NY, USA, 247–248 (1994).
   Google Scholar
• English JC, Laws RA, Keough GC et al. Dermatoses of the glans penis and prepuce. J. Am. Acad. Dermatol.37, 1–24 (1997).
   PubMed Web of Science ®Google Scholar
• Mroczkowski TF. Vulvodynia – a dermatovenereologist’s perspective. Int. J. Dermatol.37, 567–569 (1998).
   PubMed Web of Science ®Google Scholar
• Goetsch MF. Vulvar vestibulitis: prevalence and history features in a general gynecological practice population. Am. J. Obstet. Gynecol.164, 1609–1616 (1991).
   PubMed Web of Science ®Google Scholar
• Baggish MS, Miklos JR. Vulvar pain syndrome: a review. Obstet. Gynecol. Surg.50, 618–627 (1995).
   PubMedGoogle Scholar
• Lynch PJ. Vulvodynia: a syndrome of unexplained vulvar pain, psychologic disability and sexual dysfunction. The 1985 ISSVD Presidential Address. J. Reprod. Med.31, 773 (1986).
   PubMed Web of Science ®Google Scholar
• McKay M. Vulvodynia. Arch. Dermatol.125, 256–262 (1989).
   PubMed Web of Science ®Google Scholar
• Lewis FM, Shah M, Gawkrodger DJ. Contact sensitivity in prurutis vulvae: patch test results and clinical outcome. Am. J. Contact Dermat.8(3), 137–140 (1997).
   PubMedGoogle Scholar
• Goldman L, Kitzmiller KW. Perianal atrophoderma from topical corticosteroids. Arch. Dermatol.107, 611–612 (1973).
   PubMedGoogle Scholar
• Lim HW, Buchness MR, Ashinoff R, Soter NA. Chronic actinic dermatitis. Arch. Dermatol.126, 317–323 (1990).
   PubMedGoogle Scholar
• Roelandts R. Chronic actinic dermatitis. J. Am. Acad. Dermatol.28, 240–249 (1993).
   PubMed Web of Science ®Google Scholar
• Norris P, Hawk J. Chronic actinic dermatitis. A unifying concept. Editorials. Arch. Dermatol.126, 376–378 (1990).
   PubMedGoogle Scholar
• Lim HW, Morison WL, Kamide R et al. Chronic actinic dermatitis. Arch. Dermatol.130, 1284–1289 (1994).
   PubMed Web of Science ®Google Scholar
• Lim HW, Cohen D, Soter NA. Chronic actinic dermatitis: results of patch and photopatch tests with compositae, fragrances, and pesticides. J. Am. Acad. Dermatol.38, 108–111 (1998).
   PubMed Web of Science ®Google Scholar
• Menage H, Ross JS, Norris PG et al. Contact and photocontact sensitization in chronic actinic dermatitis: sesquiterpene lactone mix is an important allergen. Br. J. Dermatol.132, 543–547 (1995).
   PubMed Web of Science ®Google Scholar
• Frain-Bell W, Johnson BE. Contact allergic sensitivity plants and the photosensitivity dermatitis and actinic reticuloid syndrome. Br. J. Dermatol.101, 503–512 (1979).
   PubMed Web of Science ®Google Scholar
• Frain-Bell W, Scatchard M. The association of photosensitivity and atopy in the child. Br J. Dermatol.85, 105–110 (1971).
   PubMed Web of Science ®Google Scholar
• Addo HA, Ferguson J, Johnson BE, Frain-Bell W. The relationship between exposure to fragrance materials and persistent light reaction in the photosensitivity dermatitis with actinic reticuloid syndrome. Br. J. Dermatol.107, 261–274 (1982).
   PubMed Web of Science ®Google Scholar
• Guin JD. Eyelid dermatitis: experience in 203 cases. J. Am. Acad. Dermatol.47, 755–765 (2002).
   PubMed Web of Science ®Google Scholar
• El-Samahy MH, El-Kerdani T. Value of patch testing in atopic dermatitis. Am. J. Contact Dermat.8, 154–157 (1997).
   PubMedGoogle Scholar
• Beltrani VS. The role of dust mites in atopic dermatitis. Contact Derm.17, 431–441 (1997).
   Google Scholar
• Eisenlohr JE. Glaucoma following the prolonged use of topical steroid medication to the eyelids. J. Am. Acad. Dermatol.8, 878–881 (1983).
   PubMed Web of Science ®Google Scholar
• May P, Stein EJ, Ryter RJ, Hirsh FS, Michel B, Levy RP. Cushing syndrome from percutaneous absorption of triamcinolone cream. Arch. Intern. Med.136, 612–613 (1976).
   PubMedGoogle Scholar
• Gilbertson EO, Spellman MC, Piacquadio DJ, Mulford MI. Super potent topical corticosteroids use associated with adrenal suppression: clinical considerations. J. Am. Acad. Dermatol.38, 318–321 (1998).
   PubMed Web of Science ®Google Scholar
• Marks R, Sawyer M. Glucocorticoid-induced vasoconstriction in human skin. Arch. Dermatol.122, 881–883 (1986).
   PubMedGoogle Scholar
• Lembeck F. Mediators of vasodilatation in the skin. Br. J. Dermatol.109, 1–9 (1983).
   PubMed Web of Science ®Google Scholar
• Shah VP, Peck CC, Skelly JP. ‘Vasoconstriction’ – skin blanching-assay for glucocorticoids-a critique. Arch. Dermatol.125, 1558–1561 (1989).
   PubMedGoogle Scholar
• Ganong WF. Cardiovascular regulatory mechanisms. In: Review of Medical Physiology. Holmes SA (Ed.). Appleton & Lange, CT, USA, 550–551 (1991).
   Google Scholar
• Berne RM, Levy MN. The microcirculation and lymphatics. In:Physiology 4th Edition. Underdown E (Ed.). Mosby, MO, USA, 429–432 (1998).
   Google Scholar
• Clayton G, Clayton F. Patty’s Industrial Hygiene and Toxicology, 3rd Edition. John Wiley & Sons 26, 4099 & 4202 (1982).
   Google Scholar
• Ellenhorn M, Barceloux D. Medical Toxicology: Diagnosis and Treatment of Human Poisoning. Elsevier Sci. Pub. Co., 844–851 (1988).
   Google Scholar
• Marzining M, Nussler AK, Stadler J et al. Improved methods to measure end products of nitric oxide in biological fluids. Nitric Oxide Biol. Chem.12, 177–189 (1997).
   Google Scholar
• Makela S, Yazdanpanah M, Adatia I, Ellis G. Disposable surgical gloves and Pasteur pipettes as potential sources of contamination in nitrate and nitrate essays. Clin. Chem.43(12), 2418 (1997).
   PubMed Web of Science ®Google Scholar
• Moshage H, Stegeman CA, Jansen PL. Determination of nitrite and nitrate in stored urine. Clin. Chem.44(8), 1780–1781 (1998).
   PubMed Web of Science ®Google Scholar
• Granger DL, Taintor RR, Boockvar KS, Hibbs JB Jr. Measurement of nitrate and nitrite in biological samples using nitrate reductase and Greiss reaction. Methods Enzymol.268, 142–151 (1996).
   PubMed Web of Science ®Google Scholar
• Sorenson GW, Odom RB. Axillary and inguinal striae induced by systemic absorption of topical corticosteroid. Cutis17, 355–356 (1976).
   PubMedGoogle Scholar
• Deffer TA, Goette DK. Distal phalangeal atrophy secondary to topical steroid therapy. Arch. Dermatol.123, 571–572 (1987).
   PubMedGoogle Scholar
• Wolf R, Tur E, Brenner S. Corticosteroid-induced disappearing digit. J. Am. Acad. Dermatol.23, 755–756 (1990).
   PubMed Web of Science ®Google Scholar
• Dooms-Goossens A. Corticosteroid contact allergy: a challenge to patch testing. Am. J. Contact Dermat.4, 120–122 (1993).
   Google Scholar
• Jagodzinski LJ, Taylor JS, Oriba H. Allergic contact dermatitis from topical corticosteroid preparations. Am. J. Contact Dermat.6, 67–74 (1995).
   Google Scholar
• Schoenmakers A, Vermorken A, Degreef H, Dooms-Goossens A. Corticosteroid or steroid allergy? Contact Derm.26, 159–162 (1992).
   PubMed Web of Science ®Google Scholar
• Wilkinson SM, English JSC. Hydrocortisone sensitivity: clinical features of fifty-nine cases. J. Am. Acad. Dermatol.27, 683–687 (1992).
   PubMed Web of Science ®Google Scholar
• Reitamo S, Lauerma S, Stubb S et al. Delayed hypersensitivity to topical corticosteroids. J. Am. Acad. Dermatol.14, 582–598 (1986).
   PubMed Web of Science ®Google Scholar
• Guin JD. Contact sensitivity to topical corticosteroids. J. Am. Acad. Dermatol.10, 773–782 (1984).
   PubMed Web of Science ®Google Scholar
• Lauerma AI, Kanerva L. Contact allergy to corticosteroids. Int. J. Dermatol.35, 92–94 (1996).
   PubMed Web of Science ®Google Scholar
• Murata Y, Kumano K, Ueda T et al. Systemic contact dermatitis caused by systemic corticosteroid use. Arch. Dermatol.133, 1053–1054 (1997).
   PubMedGoogle Scholar
• English JSC, Ford G, Beck MH et al. Allergic contact dermatitis from topical and systemic steroids. Contact Derm.23, 196–198 (1990).
   PubMed Web of Science ®Google Scholar
• Lauerma AI, Reitamo S. Contact allergy to corticosteroids. J. Am. Acad. Dermatol.28, 618–622 (1993).
   PubMed Web of Science ®Google Scholar
• Sholz JR. Corticosteroid contact allergic dermatitis-some questions. Am. J. Contact Dermat.1, 114–142 (1990).
   Google Scholar
• Farrel AJ, Blake DR. Nitric oxide. Ann. Rhuem. Dis.55, 7–20 (1996).
   PubMed Web of Science ®Google Scholar
• Ochoa JB, Udekwu AO, Billiar TR, Cirram RD, Simmons RL, Peitzman AB. Nitric oxide levels in patients after trauma and during sepsis. Ann. Surg.214, 621–626 (1991).
   PubMed Web of Science ®Google Scholar
• Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev.43, 109–142 (1991).
   PubMed Web of Science ®Google Scholar
• Parks DJ, Cheung MK, Chan CC, Roberge FG. The role of nitric oxide in uveitis. Arch. Ophthalmol.112, 544–546 (1994).
   PubMedGoogle Scholar
• Everelioglu C, Turkoz Y, Hamdi ER, Inaloz S, Ozbek E, Cekman M. Increased nitric oxide production in patients with Behcet’s disease: is it a new activity marker? J. Am. Acad. Dermatol.46, 50–54 (2002).
   PubMed Web of Science ®Google Scholar
• Rapaport M, Lebwohl M. Corticosteroid addiction and withdrawal in the atopic. Clin. Dermatol.21(3), 201–214 (2003).
   PubMed Web of Science ®Google Scholar
• Shaffrali CG, Colver GB, Messenger AG, Gawkrodger DJ. Experience with low dose methotrexate for the treatment of eczema in the elderly. J. Am. Acad. Dermatol.48, 417–419 (2002).
   Web of Science ®Google Scholar
• Sidbury R, Hanifin JM. Old, new, and emerging therapies for atopic dermatitis. Dermatol. Clin.18, 1–11 (2000).
   PubMed Web of Science ®Google Scholar
• Ellis CN, Drake LA, Pendergast MM, Abramovits W et al. Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical steroids in adults with moderate to severe atopic dermatitis. J. Am. Acad. Dermatol.48, 553–563 (2002).
   Web of Science ®Google Scholar
• Jolles S, Hughes J, Rustin M. Intracellular interleukin-4 profiles during high-dose intravenous immunoglobulin treatment of therapy-resistant atopic dermatitis. J. Am. Acad. Dermatol.40, 121–123 (1999).
   PubMed Web of Science ®Google Scholar
• Berth-Jones J. Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial. Br. J. Dermatol.147, 324–330 (2002).
   PubMed Web of Science ®Google Scholar
• Ljubojeviae S, Basta-Juzbasiae A, Lipozeneiae J. Steroid dermatitis resembling rosacea: aetiopathogenesis and treatment. J. Eur. Acad. Derm. Venereo.16(2), 121–126 (2002).
   PubMed Web of Science ®Google Scholar
• Topical steroid allergy and dependence. Prescrire Int.14(75), 21–22 (2005).
   PubMedGoogle Scholar
• Chu CY. The use of 1% pimecrolimus cream for the treatment of steroid-induced rosacea. Br. J. Dermatol.152(2), 396–399 (2005).
   PubMed Web of Science ®Google Scholar
• Meurer M, Fartasch M, Albrecht G et al. Long-term efficacy and safety of pimecrolimus cream 1% in adults with moderate atopic dermatitis. Dermatology208(4), 365–372 (2004).
   PubMed Web of Science ®Google Scholar
• Rapaport MJ, Rapaport VH. Serum nitric oxide levels in “red” patients: separating corticosteroid-addicted patients from those with chronic eczema. Arch. Dermatol.140, 1013 (2004).
   PubMedGoogle Scholar